Development of Adenovirus serotype 10 as a vector for gene therapy

被引：0
|
作者：
Davies, James [1 ]
Uusi-Kerttula, Hanni [1 ]
Chester, John [1 ]
Parker, Alan [1 ]
机构：
[1] Cardiff Univ, Cardiff, S Glam, Wales
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
PO24
引用
收藏
页码：A29 / A29
页数：1
相关论文
共 50 条
  • [1] Development of adenovirus serotype 35 as a gene transfer vector
    Reddy, PS
    Ganesh, S
    Limbach, MP
    Brann, T
    Pinkstaff, A
    Kaloss, M
    Kaleko, M
    Connelly, S
    VIROLOGY, 2003, 311 (02) : 384 - 393
  • [2] Human adenovirus serotype 10 (HAdV-D10) - a novel candidate vector for gene therapy applications
    Bates, E. A.
    Uusi-Kerttula, H. K.
    Davies, J. A.
    Vanova, J.
    Baker, A. T.
    Cole, D. K.
    Rizkallah, P. J.
    Chester, J. D.
    Parker, A. L.
    HUMAN GENE THERAPY, 2019, 30 (08) : A17 - A17
  • [3] Development of Adenovirus Serotype 4 Oncolytic and Gene Therapy Vectors as an Alternative to Adenovirus Serotype 5
    Sallard, Erwan
    Schellhorn, Sebastian
    Knocks, Maximilian Maximilian
    Schulte, Lukas
    Klimovitskii, Alexander
    van den Boom, Alexander
    Zhang, Wenli
    Ehrhardt, Anja
    Ehrke-Schulz, Eric
    MOLECULAR THERAPY, 2023, 31 (04) : 565 - 565
  • [4] Adenovirus serotype 35: Genome sequence and gene transfer vector development
    Gao, WT
    Robbins, PD
    Gambotto, A
    CANCER GENE THERAPY, 2003, 10 : S21 - S21
  • [5] Adenovirus serotype 35: Genome sequence and gene transfer vector development
    Gao, WT
    Sun, HJ
    Robbins, PD
    Gambotto, A
    MOLECULAR THERAPY, 2003, 7 (05) : S194 - S194
  • [6] Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5
    Sallard, Erwan
    Schulte, Lukas
    van den Boom, Alexander
    Klimovitskii, Alexander
    Knierer, Julius
    Hagedorn, Claudia
    Knocks, Maximilian
    Zhang, Wenli
    Kreppel, Florian
    Ehrhardt, Anja
    Ehrke-Schulz, Eric
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
  • [7] Development of oncolytic and gene therapy vectors based on Adenovirus serotype 4 as an alternative to Adenovirus serotype 5
    Sallard, E.
    Schellhorn, S.
    Knocks, M.
    Schulte, L.
    Klimovitskii, A.
    Zhang, W.
    Ehrke-Schulz, E.
    Ehrhardt, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A127 - A128
  • [8] Development of oncolytic and gene therapy vectors based on Adenovirus serotype 4 as an alternative to Adenovirus serotype 5
    Sallard, E.
    Schellhorn, S.
    Knocks, M.
    Schulte, L.
    Klimovitskii, A.
    van den Boom, A.
    Zhang, W.
    Ehrhardt, A.
    Ehrke-Schulz, E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A52 - A52
  • [9] A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications
    Bliss, Carly M.
    Hulin-Curtis, Sarah L.
    Williams, Marta
    Maruskova, Mahulena
    Davies, James A.
    Statkute, Evelina
    Baker, Alexander T.
    Stack, Louise
    Kerstetter, Lucas
    Kerr-Jones, Lauren E.
    Milward, Kate F.
    Russell, Gabrielle
    George, Sarah J.
    Badder, Luned M.
    Stanton, Richard J.
    Coughlan, Lynda
    Humphreys, Ian R.
    Parker, Alan L.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (03)
  • [10] Development of a Targeted Gene Vector Platform Based on Simian Adenovirus Serotype 24
    Belousova, Natalya
    Mikheeva, Galina
    Xiong, Chiyi
    Soghomonian, Suren
    Young, Daniel
    Le Roux, Lucia
    Naff, Katherine
    Bidaut, Luc
    Wei, Wei
    Li, Chun
    Gelovani, Juri
    Krasnykh, Victor
    JOURNAL OF VIROLOGY, 2010, 84 (19) : 10087 - 10101
12345